Citizens Jmp upgraded shares of U.S. Physical Therapy (NYSE:USPH – Free Report) to a strong-buy rating in a report published on Monday morning,Zacks.com reports.
Other analysts also recently issued reports about the company. JMP Securities initiated coverage on U.S. Physical Therapy in a research report on Monday. They set an “outperform” rating and a $113.00 price objective for the company. JPMorgan Chase & Co. lifted their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Tuesday, December 3rd. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the company from $100.00 to $115.00 in a research note on Monday. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Finally, Barrington Research restated an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $114.00.
Read Our Latest Stock Analysis on USPH
U.S. Physical Therapy Trading Down 0.6 %
U.S. Physical Therapy Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date was Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 187.23%.
Insider Buying and Selling
In other news, Director Nancy Ham sold 1,172 shares of U.S. Physical Therapy stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $96.72, for a total value of $113,355.84. Following the completion of the transaction, the director now owns 1,112 shares in the company, valued at approximately $107,552.64. This trade represents a 51.31 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares in the company, valued at $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,412 shares of company stock valued at $706,605 in the last ninety days. Company insiders own 1.70% of the company’s stock.
Hedge Funds Weigh In On U.S. Physical Therapy
Large investors have recently bought and sold shares of the business. Canada Pension Plan Investment Board purchased a new position in U.S. Physical Therapy in the second quarter valued at approximately $28,000. Innealta Capital LLC acquired a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at $30,000. Quest Partners LLC grew its position in shares of U.S. Physical Therapy by 2,808.3% in the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after buying an additional 337 shares during the last quarter. Quarry LP raised its stake in U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after acquiring an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC purchased a new stake in U.S. Physical Therapy in the second quarter valued at $51,000.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Read More
- Five stocks we like better than U.S. Physical Therapy
- What Are the U.K. Market Holidays? How to Invest and Trade
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- What Are Dividends? Buy the Best Dividend Stocks
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- What Are Growth Stocks and Investing in Them
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.